| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.45B | — | +16.8% |
| Cost of Revenue | $4.80B | — | +22.1% |
| R&D Expense | $211.0M | — | +6.6% |
| SG&A Expense | $1.27B | — | +21.1% |
| Pre-tax Income | $1.11B | — | -5.9% |
| Income Tax | $240.0M | — | +13.2% |
| Net Income | $866.0M | — | -10.2% |
| EPS (Basic) | $2.23 | — | -9.3% |
| EPS (Diluted) | $2.22 | — | -9.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $565.0M | -9.2% | -68.2% |
| Short-term Investments | $186.0M | +2.8% | +14.8% |
| Accounts Receivable | $6.37B | +18.2% | +25.0% |
| Inventory | $5.15B | +9.0% | +17.2% |
| Current Assets | $14.01B | +13.4% | +12.6% |
| Total Assets | $55.09B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $507.0M | — | +113.0% |
| Capital Expenditures | $193.0M | — | +31.3% |
| Investing Cash Flow | -$11.38B | — | -1022.5% |
| Financing Cash Flow | $10.80B | — | +4524.6% |
| Free Cash Flow | $314.0M | — | +245.1% |
| +40.5% |
| Current Liabilities | $11.74B | +25.3% | +23.3% |
| Long-term Debt | $18.62B | +88.2% | +100.7% |
| Stockholders' Equity | $19.72B | +1.5% | +6.6% |